GLOBAL BLOOD THERAPEUTICS IN's ticker is GBT and the CUSIP is 37890U108. A total of 93 filers reported holding GLOBAL BLOOD THERAPEUTICS IN in Q2 2016. The put-call ratio across all filers is 1.17 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2017 | $969,000 | -45.8% | 31,200 | -52.3% | 1.38% | -10.1% |
| Q2 2017 | $1,787,000 | -6.7% | 65,350 | +25.7% | 1.53% | -14.4% |
| Q1 2017 | $1,916,000 | +340.5% | 52,000 | +72.8% | 1.79% | +281.2% |
| Q4 2016 | $435,000 | -37.3% | 30,100 | 0.0% | 0.47% | -29.7% |
| Q3 2016 | $694,000 | +39.1% | 30,100 | 0.0% | 0.67% | +27.0% |
| Q2 2016 | $499,000 | – | 30,100 | – | 0.52% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Foresite Capital Management III, LLC | 460,000 | $14,872,000 | 13.19% |
| VHCP Management II, LLC | 141,611 | $4,578,000 | 3.76% |
| Perceptive Advisors | 1,186,630 | $38,363,000 | 2.84% |
| RTW INVESTMENTS, LP | 175,156 | $5,663,000 | 1.87% |
| Casdin Capital, LLC | 65,000 | $2,101,000 | 1.86% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 1,163,811 | $37,626,000 | 1.52% |
| RA Capital Management | 457,142 | $14,779,000 | 1.46% |
| VHCP Management, LLC | 60,691 | $1,962,000 | 1.19% |
| Iguana Healthcare Management, LLC | 110,000 | $3,556,000 | 1.17% |
| Partner Investment Management, L.P. | 15,634 | $505,000 | 0.83% |